Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
UBS
Chubb
Daiichi Sankyo
Covington
Dow
QuintilesIMS
Fuji

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203772

« Back to Dashboard

NDA 203772 describes ZOLMITRIPTAN, which is a drug marketed by Alembic Pharms Ltd, Apotex Inc, Glenmark Generics, Jubilant Generics, Macleods Pharms Ltd, Zydus Pharms Usa Inc, Ajanta Pharma Ltd, Appco Pharma Llc, Aurobindo Pharma Ltd, Invagen Pharms, Mylan Pharms Inc, Pld Acquisitions Llc, Sun Pharma Global, and Teva Pharms Usa, and is included in nineteen NDAs. It is available from sixteen suppliers. Additional details are available on the ZOLMITRIPTAN profile page.

The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 203772
Tradename:ZOLMITRIPTAN
Applicant:Macleods Pharms Ltd
Ingredient:zolmitriptan
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 203772
Suppliers and Packaging for NDA: 203772
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOLMITRIPTAN zolmitriptan TABLET;ORAL 203772 ANDA Macleods Pharmaceuticals Limited 33342-112 N 33342-112-10
ZOLMITRIPTAN zolmitriptan TABLET;ORAL 203772 ANDA Macleods Pharmaceuticals Limited 33342-112 N 33342-112-74

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Sep 30, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Sep 30, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Cerilliant
Accenture
Cipla
Cantor Fitzgerald
Boehringer Ingelheim
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.